» Articles » PMID: 27652202

From Diagnosis to Therapy in Lung Cancer: Management of CT Detected Pulmonary Nodules, a Summary of the 2015 Chinese-German Lung Cancer Expert Panel

Abstract

The first Chinese-German Lung Cancer Expert Panel was held in November 2015 one day after the 7th Chinese-German Lung Cancer Forum, Shanghai. The intention of the meeting was to discuss strategies for the diagnosis and treatment of lung cancer within the context of lung cancer screening. Improved risk classification criteria and novel imaging approaches for screening populations are highly required as more than half of lung cancer cases are false positive during the initial screening round if the National Lung Screening Trial (NLST) demographic criteria [≥30 pack years (PY) of cigarettes, age ≥55 years] are applied. Moreover, if the NLST criteria are applied to the Chinese population a high number of lung cancer patients are not diagnosed due to non-smoking related risk factors in China. The primary goal in the evaluation of pulmonary nodules (PN) is to determine whether they are malignant or benign. Volumetric based screening concepts such as investigated in the Dutch-Belgian randomized lung cancer screening trial (NELSON) seem to achieve higher specificity. Chest CT is the best imaging technique to identify the origin and location of the nodule since 20% of suspected PN found on chest X-ray turn out to be non-pulmonary lesions. Moreover, novel state-of-the-art CT systems can reduce the radiation dose for lung cancer screening acquisitions down to a level of 0.1 mSv with improved image quality to novel reconstruction techniques and thus reduce concerns related to chest CT as the primary screening technology. The aim of the first part of this manuscript was to summarize the current status of novel diagnostic techniques used for lung cancer screening and minimally invasive treatment techniques for progressive PNs that were discussed during the first Chinese-German Lung Cancer. This part should serve as an educational part for the readership of the techniques that were discussed during the Expert Panel. The second part summarizes the consensus recommendations that were interdisciplinary discussed by the Expert Panel.

Citing Articles

Incidence and Mortality Life-Attributable Risks for Patients Subjected to Recurrent CT Examinations and Cumulative Effective Dose Exceeding 100 mSv.

Dalah E, B Mohamed A, M Al Bastaki U, A Khan S Clin Pract. 2024; 14(4):1550-1561.

PMID: 39194929 PMC: 11353021. DOI: 10.3390/clinpract14040125.


Implementation of sodium alginate-FeO to localize undiagnosed small pulmonary nodules for surgical management in a preclinical rabbit model.

Zhang Z, Lv L, Shi A, Li Y, Wang T, Guo Y Sci Rep. 2022; 12(1):9979.

PMID: 35705647 PMC: 9200847. DOI: 10.1038/s41598-022-13884-w.


Efficacy of thoracoscopic anatomical segmentectomy for small pulmonary nodules.

Li H, Liu Y, Ling B, Hu B World J Clin Cases. 2020; 8(11):2227-2234.

PMID: 32548153 PMC: 7281044. DOI: 10.12998/wjcc.v8.i11.2227.


Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Hu Y, Hu H, Miao L, Zhao X, Gu W, Heng W Thorac Cancer. 2018; 9(3):376-383.

PMID: 29341459 PMC: 5832471. DOI: 10.1111/1759-7714.12588.


How to diagnose pulmonary nodules: from screening to therapy.

Yao Y, Lv T, Song Y Transl Lung Cancer Res. 2017; 6(1):3-5.

PMID: 28331818 PMC: 5344842. DOI: 10.21037/tlcr.2017.01.03.

References
1.
Andreano A, Huang Y, Meloni M, Lee Jr F, Brace C . Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys. 2010; 37(6):2967-73. PMC: 2887908. DOI: 10.1118/1.3432569. View

2.
Lee H, Lee K, Ahn M, Hwang H, Lee J, Park K . New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy. Lung Cancer. 2010; 73(1):63-9. DOI: 10.1016/j.lungcan.2010.10.019. View

3.
Haubenreisser H, Meyer M, Sudarski S, Allmendinger T, Schoenberg S, Henzler T . Unenhanced third-generation dual-source chest CT using a tin filter for spectral shaping at 100kVp. Eur J Radiol. 2015; 84(8):1608-1613. DOI: 10.1016/j.ejrad.2015.04.018. View

4.
Sroufe R, Kong F . Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?. Transl Lung Cancer Res. 2015; 4(4):438-47. PMC: 4549472. DOI: 10.3978/j.issn.2218-6751.2015.07.22. View

5.
Planche O, Teriitehau C, Boudabous S, Robinson J, Rao P, Deschamps F . In vivo evaluation of lung microwave ablation in a porcine tumor mimic model. Cardiovasc Intervent Radiol. 2012; 36(1):221-8. DOI: 10.1007/s00270-012-0399-8. View